183 related articles for article (PubMed ID: 64244)
1. Properties of erythrocyte catalase from homozygotes and heterozygotes for Swiss-type acatalasemia.
Aebi H; Wyss SR; Scherz B; Gross J
Biochem Genet; 1976 Oct; 14(9-10):791-807. PubMed ID: 64244
[TBL] [Abstract][Full Text] [Related]
2. Properties of leukocyte catalase in Swiss type acatalasemia: a comparative study of normals, heterozygotes and homozygotes.
Wyss SR; Aebi H
Enzyme; 1975; 20(5):257-68. PubMed ID: 811469
[TBL] [Abstract][Full Text] [Related]
3. Properties of erythrocyte catalase from heterozygotes for Japanese type acatalasemia.
Ogata M; Mizugaki J
Acta Med Okayama; 1979 Jun; 33(3):205-11. PubMed ID: 40400
[TBL] [Abstract][Full Text] [Related]
4. Carrier state in human acatalasemia.
NISHIMURA ET; HAMILTON HB; KOBARA TY; TAKAHARA S; OGURA Y; DOI K
Science; 1959 Aug; 130(3371):333-4. PubMed ID: 13668563
[TBL] [Abstract][Full Text] [Related]
5. Polyacrylamide gradient gel electrophoretic studies of residual catalase in acatalasemia.
Ogata M; Mizugaki J; Izumi M; Taketa K
Physiol Chem Phys Med NMR; 1983; 15(1):31-5. PubMed ID: 6647570
[TBL] [Abstract][Full Text] [Related]
6. Molecular hybridization in heterozygotes for Swiss-type acatalasemia.
Aebi H; Wyss SR
Monogr Hum Genet; 1978; 10():200-4. PubMed ID: 723894
[No Abstract] [Full Text] [Related]
7. Nature of residual erythrocyte catalase activity in Swiss-type acatalasemia.
Shapira E; Ben-Yoseph Y; Aebi H
Enzyme; 1974; 17(5):307-18. PubMed ID: 4209585
[No Abstract] [Full Text] [Related]
8. Properties of catalase subfractions separated by chromatofocusing of acatalasemia hemolysates.
Ogata M; Mizugaki J
Acta Med Okayama; 1982 Feb; 36(1):73-6. PubMed ID: 7064736
[TBL] [Abstract][Full Text] [Related]
9. The role of enzyme variants, polymorphisms and enzyme hybrids in enzyme deficiency conditions.
Aebi H; Wyss SR
Acta Biol Med Ger; 1981; 40(4-5):537-41. PubMed ID: 7315100
[TBL] [Abstract][Full Text] [Related]
10. Properties of human erythrocyte catalases after crosslinking with bifunctional reagents. Symmetry of the quaternary structure.
Hajdu J; Wyss SR; Aebi H
Eur J Biochem; 1977 Oct; 80(1):199-207. PubMed ID: 923573
[TBL] [Abstract][Full Text] [Related]
11. Immunotitration of the catalase in the blood of Japanese subjects and mice suffering from acatalasemia and hypocatalasemia.
Ogata M; Fujii Y
Physiol Chem Phys Med NMR; 1992; 24(4):261-9. PubMed ID: 1296208
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte metabolism against oxidation in Japanese acatalasemia.
Takahara S; Ogata M
Monogr Hum Genet; 1978; 10():205-11. PubMed ID: 723895
[No Abstract] [Full Text] [Related]
13. A novel human catalase mutation (358 T-->del) causing Japanese-type acatalasemia.
Hirono A; Sasaya-Hamada F; Kanno H; Fujii H; Yoshida T; Miwa S
Blood Cells Mol Dis; 1995; 21(3):232-4. PubMed ID: 8673475
[TBL] [Abstract][Full Text] [Related]
14. Characterization of acatalasemia detected in two Hungarian sisters.
Góth L
Enzyme; 1992; 46(4-5):252-8. PubMed ID: 1292935
[TBL] [Abstract][Full Text] [Related]
15. [On the cellular distribution of catalase in the blood of homozygous and heterozygous defect-carriers (acatalasia)].
Aebi H; Cantz M
Humangenetik; 1966; 3(1):50-63. PubMed ID: 5986055
[No Abstract] [Full Text] [Related]
16. Properties of acatalasic cells growing in vitro.
KROOTH RS; HOWELL RR; HAMILTON HB
J Exp Med; 1962 Feb; 115(2):313-28. PubMed ID: 14459853
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human residual catalase of an acatalasemic patient by isoelectric focusing and sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by electrophoretic blotting and immunodetection.
Ogata M; Suzuki K; Satoh Y
Electrophoresis; 1989 Mar; 10(3):194-8. PubMed ID: 2651112
[TBL] [Abstract][Full Text] [Related]
18. The level and stability of residual catalase in cultured acatalasemic skin fibroblasts.
Ogata M; Fujii Y; Meguro T; Kira S; Matsuda A; Izushi F; Kimoto T; Takahara S
Acta Med Okayama; 1987 Oct; 41(5):201-4. PubMed ID: 3687491
[TBL] [Abstract][Full Text] [Related]
19. A new variant glyoxalase I allele that is readily detectable in stimulated lymphocytes and lymphoblastoid cell lines but not in circulating lymphocytes or erythrocytes.
Kavathas P; DeMars R
Am J Hum Genet; 1981 Nov; 33(6):935-45. PubMed ID: 7325156
[TBL] [Abstract][Full Text] [Related]
20. Mammalian acatalasemia: the perspectives of bioinformatics and genetic toxicology.
Ogata M; Wang DH; Ogino K
Acta Med Okayama; 2008 Dec; 62(6):345-61. PubMed ID: 19122680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
